Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Pascual

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Antiviral Therapy|October 14, 2014
Intellectual property rights, market competition and access to affordable antiretroviralsFernando Pascual
Journal of Public Health Policy|July 17, 2015
Viewpoint: Counterfeit medicines and substandard medicines: Different problems requiring different solutionsEllen 't Hoen, Fernando Pascual
The New England Journal of Medicine|June 25, 2004
HIV drug resistanceAlexandra Calmy, Fernando Pascual, Nathan Ford
Lancet (London, England)|July 28, 2004
First-line and second-line antiretroviral therapyAlexandra Calmy, Fernando Pascual, Nathan Ford
Oncology Research|February 14, 2007
In vivo treatment of melanoma (B16F10) with a homeopathic agent and with a cytokine (IFN-alpha)Fernando Pascual-Carpe, Vicente Vicente-Ortega, Matilde Campos-Aranda, et al.
Medicina Clinica|January 23, 2014
[Acute sensory-motor axonal neuropathy (Guillain-Barre syndrome) following vertebroplasty]Alba Velázquez Benito, Elena Bellosta Diago, Sonia Santos Lasaosa, et al.
Lancet (London, England)|September 26, 2006
(The Lancet)red: a missed opportunityAlexandra Calmy, Fernando Pascual, Sheila Shettle, et al.
Journal of the International AIDS Society|December 8, 2015
Optimizing drugs to reach treatment targets for children and adolescents living with HIVMartina Penazzato, Janice Lee, Edmund Capparelli, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 28, 2009
In vitro and in vivo effect of IFNalpha on B16F10 melanoma in two models: subcutaneous (C57BL6J mice) and lung metastasis (Swiss mice)Cristina Martínez Conesa, Nuria Alvarez Sánchez, Vicente Vicente Ortega, et al.
BMC Infectious Diseases|April 23, 2026
Assessing N. gonorrhoeae prevalence and testing capacity for new treatment rollout: a scoping review for Cambodia, Thailand, Vietnam and South AfricaMatilda Subek Simon, Alla Babekr, Moaaz A Elhadad, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Antiviral Therapy|October 14, 2014
Intellectual property rights, market competition and access to affordable antiretroviralsFernando Pascual
Journal of Public Health Policy|July 17, 2015
Viewpoint: Counterfeit medicines and substandard medicines: Different problems requiring different solutionsEllen 't Hoen, Fernando Pascual
The New England Journal of Medicine|June 25, 2004
HIV drug resistanceAlexandra Calmy, Fernando Pascual, Nathan Ford
Lancet (London, England)|July 28, 2004
First-line and second-line antiretroviral therapyAlexandra Calmy, Fernando Pascual, Nathan Ford
Oncology Research|February 14, 2007
In vivo treatment of melanoma (B16F10) with a homeopathic agent and with a cytokine (IFN-alpha)Fernando Pascual-Carpe, Vicente Vicente-Ortega, Matilde Campos-Aranda, et al.
Medicina Clinica|January 23, 2014
[Acute sensory-motor axonal neuropathy (Guillain-Barre syndrome) following vertebroplasty]Alba Velázquez Benito, Elena Bellosta Diago, Sonia Santos Lasaosa, et al.
Lancet (London, England)|September 26, 2006
(The Lancet)red: a missed opportunityAlexandra Calmy, Fernando Pascual, Sheila Shettle, et al.
Journal of the International AIDS Society|December 8, 2015
Optimizing drugs to reach treatment targets for children and adolescents living with HIVMartina Penazzato, Janice Lee, Edmund Capparelli, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 28, 2009
In vitro and in vivo effect of IFNalpha on B16F10 melanoma in two models: subcutaneous (C57BL6J mice) and lung metastasis (Swiss mice)Cristina Martínez Conesa, Nuria Alvarez Sánchez, Vicente Vicente Ortega, et al.
BMC Infectious Diseases|April 23, 2026
Assessing N. gonorrhoeae prevalence and testing capacity for new treatment rollout: a scoping review for Cambodia, Thailand, Vietnam and South AfricaMatilda Subek Simon, Alla Babekr, Moaaz A Elhadad, et al.
Pageof 2